Latest news

Prescription Drug Affordability Board might not deliver savings to patients
By Hannah Pfeiffer and Candace DeMatteis June 5, 2024 Boulder Daily Camera   A group of unelected state officials is pondering a decision with enormous consequences for thousands of Colorado patients battling chronic diseases. In 2021, Colorado established a Prescription Drug
OP-ED
Jun 5,2024
By Tweaking the IRA, This Legislation Could Save Lives
May 1, 2024    The impact of the Inflation Reduction Act on the price of medicine is starting to play out. Measures to cap the price of insulin at $35 a month for Medicare enrollees took effect on Jan. 1.   In 2025, the IRA will cap annual out-of-pocket prescription drug costs
In the news
May 4,2024
New Insurer Perspectives Highlight Considerable Patient Challenges Anticipated from Prescription Drug Affordability Boards
April 2, 2024 (Washington, DC) Today the Partnership to Fight Chronic Disease (PFCD) released a new white paper, “Health Plans Predict: Implementing Upper Payment Limits May Alter Formularies and Benefit Design But Won’t Reduce Patient Costs,” which details feedback from
Press release
Apr 2,2024
BIDEN ADMINISTRATION STATE OF THE UNION HIGHLIGHTS MISGUIDED PROPOSAL TO EXPAND THE INFLATION REDUCTION ACT
Unintended consequences for chronic disease patients are many   March 8, 2024 (WASHINGTON, D.C.) The Partnership to Fight Chronic Disease (PFCD) today released the following statement from Chair Ken Thorpe in response to President Biden’s State of the Union address:   “
Press release
Mar 8,2024
Biden Admin's March-In Plan Would Hurt Medical Innovation
By Ken Thorpe February 22, 2024 Law360   In December, the White House issued a new policy framework that could have devastating effects on access to cutting-edge drugs. The proposal would radically reinterpret a 43-year-old law to let the government march in and take patents
OP-ED
Feb 26,2024
DELIVERING VALUE TO PATIENTS CALLS FOR CONGRESS TO BETTER PRIORITIZE REFORMS, ABANDON FOREIGN PRICE CONTROLS
February 8, 2024 (Washington, D.C.) The Partnership to Fight Chronic Disease (PFCD) released the following statement in advance of today’s U.S. Senate Committee on Health, Education, Labor & Pensions hearing on prescription drugs:   “Reducing health care costs both for
Press release
Feb 8,2024
PRESERVING ACCESS TO SMALL MOLECULE MEDICINES CRITICAL FOR PEOPLE LIVING WITH CHRONIC CONDITIONS
  February 1, 2024 (Washington, D.C.) Today the Partnership to Fight Chronic Disease (PFCD) applauded Representatives Greg Murphy (R-NC), Don Davis (D-NC), and Brett Guthrie (R-KY) for their leadership in support of millions of Americans living with chronic disease and the introduction of the
Press release
Feb 1,2024
CHRONIC DISEASE PREVALENCE POSES ADDED CHALLENGES TO MATERNAL HEALTH FOR BLACK WOMEN
Dramatic increases in maternal mortality linked to impacts of chronic disease   October 24, 2023 (SAN DIEGO, CA) Today the Partnership to Fight Chronic Disease (PFCD) co-hosted a community seminar on the increasing connection of chronic disease and Black maternal health with California
Press release
Oct 25,2023
MEDICARE’S LIST OF DRUGS FOR PRICING PROGRAM HIGHLIGHTS ACCESS CHALLENGES FOR BENEFICIARIES
Achieving promised savings for government program will inevitably restrict patient access to decrease utilization of lifesaving medications   August 29, 2023 (WASHINGTON, D.C.) The Partnership to Fight Chronic Disease (PFCD) released the following statement today in response to the Centers
Press release
Aug 29,2023
Inflation Reduction Act will be the Achilles heel of Biden's Cancer Moonshot
Hartford Courant  8/15/23   The Biden administration just announced a new initiative to improve cancer outcomes in low-income communities across the United States.[1] It's sorely needed. Research shows cancer mortality is more than 10% higher in communities experiencing persistent
OP-ED
Aug 16,2023

Pages